Cocrystal Pharma, Inc. (COCP)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 25, 2025 | CORRESP | Neutral/Informational | Moderate | Cocrystal Pharma, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1, which was filed on September 19, 2025. They… | Read Filing EDGAR |
| Sep. 24, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has notified Cocrystal Pharma, Inc. that it will not review their registration statement filed on September 19, 2025. The letter emphasizes that the responsibility for the… | Read Filing EDGAR |
| Aug. 28, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Cocrystal Pharma, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company and its management of their responsibil… | Read Filing EDGAR |
| Aug. 13, 2025 | CORRESP | Concern from SEC | Moderate | Cocrystal Pharma, Inc. submitted a response to the SEC's comment letter dated July 30, 2025, regarding their Form 10-K for the fiscal year ended December 31, 2024. The corresponde… | Read Filing EDGAR |
| Jul. 30, 2025 | UPLOAD | Concern from SEC | High | The SEC has issued a comment letter to Cocrystal Pharma, Inc. regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the premature us… | Read Filing EDGAR |